|
Index of reports
> Cases with Febrile Neutropenia (97)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 97 Next >>
Possible Prednisone side effects in male
Reported by a individual with unspecified qualification from United States on 2012-08-21
Patient: male, weighing 42.6 kg (93.8 pounds)
Reactions: Mouth Ulceration, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 2780 mg
Doxorubicin Hydrochloride
Dosage: 152 mg
Etoposide
Dosage: 750 mg
Prednisone
Dosage: 646 mg
Rituximab (Muab C2b8 Anti Cd20)
Dosage: 810 mg
Vincristine Sulfate
Dosage: 3.6 mg
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-08-16
Patient: male, weighing 73.5 kg (161.7 pounds)
Reactions: Escherichia Urinary Tract Infection, Febrile Neutropenia, Proteus Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1370 mg
Doxorubicin Hydrochloride
Dosage: 91 mg
Prednisone
Dosage: 350 mg
Rituximab (Maab C2b8 Anti Cd20, Chimeric)
Dosage: 700 mg
Vincristine Sulfate
Dosage: 2 mg
Possible Prednisone side effects in
Reported by a individual with unspecified qualification from United States on 2012-08-07
Patient:
Reactions: Lung Infection, Febrile Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: over 30-60 minutes on day 3
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-08
End date: 2012-02-08
Cyclophosphamide
Dosage: over 30-60 minutes on day 3
Start date: 2012-07-12
End date: 2012-07-12
Cyclophosphamide
Dosage: over 30-60 minutes on day 3
Start date: 2012-03-01
End date: 2012-03-01
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, on day 3
Start date: 2012-07-12
End date: 2012-07-12
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, on day 3
Start date: 2012-03-01
End date: 2012-03-01
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, on day 3
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-08
End date: 2012-02-08
Prednisone
Dosage: 100 mg, qd on days 3-7
Administration route: Oral
Start date: 2012-03-01
End date: 2012-03-05
Prednisone
Dosage: 100 mg, qd on days 3-7
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-08
End date: 2012-02-12
Prednisone
Dosage: 100 mg, qd on days 3-7
Administration route: Oral
Start date: 2012-07-12
End date: 2012-07-12
Rituximab
Dosage: 375 mg/m2, on day 3
Start date: 2012-03-01
End date: 2012-03-01
Rituximab
Dosage: 375 mg/m2, on day 3
Start date: 2012-07-12
End date: 2012-07-12
Rituximab
Dosage: 375 mg/m2, on day 3
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-08
End date: 2012-02-08
Vincristine Sulfate
Dosage: 1.4 mg/m2, on day 3
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-08
End date: 2012-02-08
Vincristine Sulfate
Dosage: 1.4 mg/m2, on day 3
Start date: 2012-07-12
End date: 2012-07-12
Vincristine Sulfate
Dosage: 1.4 mg/m2, on day 3
Start date: 2012-03-01
End date: 2012-03-01
Vorinostat
Dosage: on day 1-9
Administration route: Oral
Start date: 2012-02-28
End date: 2012-03-07
Vorinostat
Dosage: on day 1-9
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-02-14
Vorinostat
Dosage: on day 1-5
Administration route: Oral
Start date: 2012-07-10
End date: 2012-07-14
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07
Patient:
Reactions: Hospitalisation, Neuropathy Peripheral, Vomiting, Febrile Neutropenia, Neutropenia, Neutrophil Count Decreased, Lymphoma
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: for 5 days
Indication: B-Cell Lymphoma
Prednisone
Dosage: for 5 days
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: B-Cell Lymphoma
Rituximab
Indication: B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Neupogen
Possible Prednisone side effects in 41 year old male
Reported by a physician from Canada on 2012-08-03
Patient: 41 year old male
Reactions: Ecthyma, Diarrhoea, Pseudomonas Infection, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma Stage IV
Doxorubicin HCL
Indication: B-Cell Lymphoma Stage IV
Prednisone
Indication: B-Cell Lymphoma Stage IV
Rituximab
Indication: B-Cell Lymphoma Stage IV
Vincristine
Indication: B-Cell Lymphoma Stage IV
Other drugs received by patient: Epogen; Enoxaparin Sodium; Filgrastim
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2012-07-31
Patient:
Reactions: Vomiting, Acute Leukaemia, Febrile Neutropenia, Treatment Failure, Neutropenia, Toxicity To Various Agents, Neoplasm, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Chemoradiation
Indication: Hodgkin's Disease
Cyclophosphamide
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Prednisone
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Possible Prednisone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Velcade
End date: 2012-04-10
Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil
Possible Prednisone side effects in
Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2012-07-26
Patient:
Reactions: Vomiting, Acute Leukaemia, Febrile Neutropenia, Treatment Failure, Neutropenia, Toxicity To Various Agents, Neoplasm, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Chemoradiation
Indication: Hodgkin's Disease
Cyclophosphamide
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Prednisone
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Possible Prednisone side effects in 75 year old male
Reported by a physician from United States on 2012-07-25
Patient: 75 year old male, weighing 74.8 kg (164.6 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-05-08
Docetaxel
Indication: Prostate Cancer Metastatic
Start date: 2012-05-01
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-05-01
Possible Prednisone side effects in 75 year old male
Reported by a physician from United States on 2012-07-24
Patient: 75 year old male, weighing 74.8 kg (164.6 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-05-08
Docetaxel
Indication: Prostate Cancer Metastatic
Start date: 2012-05-01
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-05-01
Possible Prednisone side effects in
Reported by a physician from Italy on 2012-07-20
Patient:
Reactions: Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma Recurrent, Mucosal Inflammation, Neurotoxicity, Sepsis, Adverse Event, Cardiotoxicity, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Lymphoma, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750 mg/m2 on day 1 for chop and 750 mg/m2 on day 2 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: 50 mg/m2 on day 1 for chop and 50 mg/m2 on day 2 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 100 mg on days 1-5 for chop and r-chop
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: 375 mg/m2 on day 1 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: 1.4 mg/m2 on day 1 for chop and 1.4 mg/m2 on day 2 for r-chop upto a maximum dose of 2 mg
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Neupogen
Possible Prednisone side effects in 32 year old female
Reported by a physician from Belgium on 2012-07-19
Patient: 32 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1215 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-28
Doxorubicin HCL
Dosage: 81 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-28
End date: 2011-12-28
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-29
End date: 2011-12-29
Prednisone
Dosage: 500 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-28
Rituximab
Dosage: 608 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-28
End date: 2011-12-28
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-28
End date: 2011-12-28
Possible Prednisone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore
Possible Prednisone side effects in female
Reported by a physician from France on 2012-07-18
Patient: female, weighing 40.0 kg (88.0 pounds)
Reactions: Pneumonia, General Physical Health Deterioration, Febrile Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Istodax
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-12
Prednisone
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Possible Prednisone side effects in 83 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17
Patient: 83 year old female, weighing 50.0 kg (110.0 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 400 mg/m2, cyclic, on day 1 of each cycle
Start date: 2010-10-15
Cyclophosphamide
Dosage: 400 mg/m2, single (cycle 5)
Start date: 2011-01-13
Doxorubicin HCL
Dosage: 25 mg/m2, cyclic, on day 1 of each cycle
Start date: 2010-10-15
Doxorubicin HCL
Dosage: 25 mg/m2, single (cycle 5)
Start date: 2011-01-13
Mabthera
Dosage: 375 mg/m2, single (cycle 5)
Start date: 2011-01-13
Mabthera
Dosage: 375 mg/m2, cyclic, one day 1 of each cycle
Start date: 2010-10-15
Prednisone
Dosage: 40 mg/m2, cyclic, from day 1 to day 4 of each cycle
Administration route: Oral
Start date: 2010-10-15
Prednisone
Dosage: 40 mg/m2, 1x/day (cycle 5)
Administration route: Oral
Start date: 2011-01-13
End date: 2011-01-17
Vincristine
Dosage: 1 mg/m2, cyclic, on day 1 of each cycle
Start date: 2010-10-15
Vincristine
Dosage: 1 mg/m2, single (cycle 5)
Start date: 2011-01-13
Other drugs received by patient: Nexium
Possible Prednisone side effects in
Reported by a physician from United States on 2012-07-16
Patient:
Reactions: Fatigue, Febrile Neutropenia, Peripheral Motor Neuropathy, Peripheral Sensory Neuropathy, Arrhythmia, Cerebral Haemorrhage
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Prednisone side effects in
Reported by a individual with unspecified qualification from Croatia (Local Name: Hrvatska) on 2012-07-13
Patient:
Reactions: Mucosal Inflammation, Multi-Organ Failure, Tumour Lysis Syndrome, Febrile Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Dexamethasone
Indication: Burkitt's Lymphoma
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Ifosfamide
Indication: Burkitt's Lymphoma
Mabthera
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Prophylaxis
Prednisone
Indication: Burkitt's Lymphoma
Vincristine
Indication: Burkitt's Lymphoma
Possible Prednisone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride
Possible Prednisone side effects in 61 year old male
Reported by a consumer/non-health professional from Germany on 2012-07-13
Patient: 61 year old male
Reactions: Candida Pneumonia, Bronchopneumonia, Febrile Neutropenia, Respiratory Distress, Organising Pneumonia, Respiratory Failure, Interstitial Lung Disease, Pseudomonal Sepsis, Opportunistic Infection, Stenotrophomonas Sepsis, Tracheitis, Septic Shock, Sinusitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-08
Campath
Dosage: 30 mg, qd
Start date: 2010-02-22
End date: 2010-02-23
Cyclophosphamide
Dosage: 1380 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Cyclophosphamide
Dosage: 690 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Doxorubicin HCL
Dosage: 92 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Doxorubicin HCL
Dosage: 46 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Pegfilgrastim
Dosage: 6 mg, qd
Start date: 2010-03-01
End date: 2010-03-01
Pegfilgrastim
Dosage: 3 mg, qd
Indication: T-Cell Lymphoma
Posaconazole
Indication: Prophylaxis
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2010-02-22
End date: 2010-02-26
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-11
Vincristine
Dosage: 2 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Vincristine
Dosage: 2 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Possible Prednisone side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-12
Patient: 67 year old male, weighing 78.0 kg (171.6 pounds)
Reactions: Multi-Organ Failure, Spinal Pain, Nausea, Sepsis, Febrile Neutropenia, Dizziness, Hepatitis B, Cough
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: .25 milligram/kilogram
Indication: Multiple Myeloma
Start date: 2009-01-29
End date: 2009-02-02
Prednisone
Dosage: 2 milligram
Indication: Multiple Myeloma
Start date: 2009-01-29
End date: 2009-02-02
Thalidomide
Dosage: 200 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-01-29
End date: 2009-02-10
Other drugs received by patient: Kalium; Metamizol; Levothyroxine Sodium; Lactulose; Tramadol HCL; Nadroparin; Pantoprazole; Tamsulosin HCL; Allopurinol; Aspirin; Amphotericin B; Nadroparin
Possible Prednisone side effects in 61 year old male
Reported by a consumer/non-health professional from Germany on 2012-07-10
Patient: 61 year old male
Reactions: Respiratory Failure, Bronchopneumonia, Pseudomonal Sepsis, Febrile Neutropenia, Septic Shock, Tracheitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-08
Campath
Dosage: 30 mg, qd
Start date: 2010-02-22
End date: 2010-02-23
Cyclophosphamide
Dosage: 1380 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Cyclophosphamide
Dosage: 690 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Doxorubicin HCL
Dosage: 46 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Doxorubicin HCL
Dosage: 92 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Pegfilgrastim
Dosage: 3 mg, qd
Indication: T-Cell Lymphoma
Pegfilgrastim
Dosage: 6 mg, qd
Start date: 2010-03-01
End date: 2010-03-01
Posaconazole
Indication: Prophylaxis
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-11
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2010-02-22
End date: 2010-02-26
Vincristine
Dosage: 2 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Vincristine
Dosage: 2 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Possible Prednisone side effects in male
Reported by a consumer/non-health professional from Germany on 2012-07-10
Patient: male, weighing 60.0 kg (132.0 pounds)
Reactions: Candida Pneumonia, Bronchopneumonia, Tachycardia, Atrial Fibrillation, Febrile Neutropenia, General Physical Health Deterioration, Lactic Acidosis, Respiratory Distress, Respiratory Failure, Skin Lesion, Pseudomonal Sepsis, Tracheitis, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2010-01-07
End date: 2010-01-08
Campath
Dosage: 30 mg, qd
Start date: 2010-02-22
End date: 2010-02-23
Cyclophosphamide
Dosage: 690 mg, once
Start date: 2010-02-22
End date: 2010-02-22
Cyclophosphamide
Dosage: 1380 mg, unk
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2010-01-07
End date: 2010-01-07
Doxorubicin HCL
Dosage: 92 mg, unk
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2010-01-07
End date: 2010-01-07
Doxorubicin HCL
Dosage: 46 mg, once
Start date: 2010-02-22
End date: 2010-02-22
Pegfilgrastim
Dosage: 6 mg, once
Start date: 2010-03-01
End date: 2010-03-01
Pegfilgrastim
Dosage: 3 mg, qd
Indication: Peripheral T-Cell Lymphoma Unspecified
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2010-01-07
End date: 2010-01-11
Prednisone
Dosage: 100 mg, qdx5
Administration route: Oral
Start date: 2010-02-22
End date: 2010-02-26
Vasopressin
Dosage: unk
Indication: Blood Pressure Management
Vincristine
Dosage: 2 mg, qd
Start date: 2010-02-22
End date: 2010-02-22
Vincristine
Dosage: 2 mg, unk
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2010-01-07
End date: 2010-01-07
Other drugs received by patient: Zienam; Posaconazole; Taranic; Zienam; Taranic; Candiohermal; Candiohermal
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-07-09
Patient: male
Reactions: Febrile Neutropenia, Proctalgia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 mg/m2
Indication: non-Hodgkin's Lymphoma
Start date: 2012-05-18
End date: 2012-07-01
Doxorubicin Hydrochloride
Dosage: 50 mg/m2
Indication: non-Hodgkin's Lymphoma
Start date: 2012-05-18
End date: 2012-07-01
Mabthera
Dosage: 375 mg/m2
Indication: non-Hodgkin's Lymphoma
Start date: 2012-05-18
End date: 2012-07-01
Prednisone
Indication: non-Hodgkin's Lymphoma
End date: 2012-07-01
Vincristine Sulfate
Dosage: 1.4 mg/m2
Indication: non-Hodgkin's Lymphoma
Start date: 2012-05-18
End date: 2012-07-01
Other drugs received by patient: Acetaminophen; Senna-Mint WAF; Pegfilgrastim; Pantoprazole; Acyclovir; Dexamethasone; Fluconazole
Possible Prednisone side effects in 73 year old male
Reported by a physician from Germany on 2012-07-06
Patient: 73 year old male
Reactions: Stenotrophomonas Infection, Febrile Neutropenia, Atrial Fibrillation, Ileus Paralytic, Multi-Organ Failure, Pneumonia Bacterial, Respiratory Failure, Cardiac Failure, Oesophagitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, q2w
Indication: T-Cell Lymphoma
Start date: 2009-06-25
End date: 2009-09-04
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: T-Cell Lymphoma
Start date: 2009-06-25
End date: 2009-09-03
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: T-Cell Lymphoma
Start date: 2009-06-25
End date: 2009-09-03
Pegfilgrastim
Dosage: 6 mg, q2w
Indication: T-Cell Lymphoma
Start date: 2009-06-29
End date: 2009-09-06
Pegfilgrastim
Indication: Prophylaxis
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2009-06-17
End date: 2009-09-10
Vincristine
Dosage: 1 mg, unk
Indication: T-Cell Lymphoma
Start date: 2009-06-17
End date: 2009-09-03
Other drugs received by patient: Ciprofloxacin
Possible Prednisone side effects in 73 year old female
Reported by a physician from Netherlands on 2012-07-04
Patient: 73 year old female, weighing 48.0 kg (105.6 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Syncope, Febrile Neutropenia, Staphylococcal Bacteraemia, Muscle Spasms
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1155 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-06-10
Cyclophosphamide
Dosage: 1155 mg, unk
Start date: 2011-07-04
Doxorubicin HCL
Dosage: 77 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-06-10
Doxorubicin HCL
Dosage: 75 mg, unk
Start date: 2011-07-04
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2007-07-19
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2011-07-04
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-06-10
Rituximab
Dosage: 577 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-06-10
Rituximab
Dosage: 560 mg, unk
Start date: 2011-07-04
Vincristine
Dosage: 2 unk, unk
Start date: 2011-07-04
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-06-10
Other drugs received by patient: Omeprazole; Perindopril Erbumine
Possible Prednisone side effects in 69 year old male
Reported by a individual with unspecified qualification from Germany on 2012-07-03
Patient: 69 year old male
Reactions: Anaemia, Febrile Neutropenia, Asthenia, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Mabthera
Indication: non-Hodgkin's Lymphoma
Prednisone
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: non-Hodgkin's Lymphoma
Possible Prednisone side effects in male
Reported by a physician from United States on 2012-06-21
Patient: male, weighing 97.5 kg (214.5 pounds)
Reactions: Febrile Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Abiraterone Acetate
Administration route: Oral
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-01-03
End date: 2012-03-11
Docetaxel
Dosage: cycle 4
Indication: Prostate Cancer Metastatic
Start date: 2012-02-28
Docetaxel
Dosage: cycle 1
Start date: 2011-12-27
Prednisone
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2011-12-27
Possible Prednisone side effects in 44 year old male
Reported by a physician from Netherlands on 2012-06-19
Patient: 44 year old male, weighing 95.0 kg (209.0 pounds)
Reactions: Upper Respiratory Tract Infection, Febrile Neutropenia, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1660 mg, unk
Indication: B-Cell Lymphoma
Start date: 2011-12-20
Doxorubicin HCL
Dosage: 110 mg, unk
Indication: B-Cell Lymphoma
Start date: 2011-12-20
Neupogen
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2011-12-21
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2011-12-20
Rituximab
Dosage: 800 mg, unk
Indication: B-Cell Lymphoma
Start date: 2011-12-20
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2011-12-20
Other drugs received by patient: Cotrim; Valaciclovir
Possible Prednisone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05
Patient: male, weighing 113.0 kg (248.7 pounds)
Reactions: Gastrointestinal Perforation, Febrile Neutropenia, Infectious Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Docetaxel
Dosage: 160 milligram
Indication: Prostate Cancer
Start date: 2010-05-18
Docetaxel
Dosage: 160 milligram
Start date: 2010-07-07
End date: 2010-07-07
Lenalidomide
Dosage: 25 milligram
Administration route: Oral
Indication: Prostate Cancer
Start date: 2010-05-18
Lenalidomide
Dosage: 25 milligram
Administration route: Oral
Start date: 2010-07-07
End date: 2010-07-13
Prednisone
Dosage: 5 milligram
Indication: Prostate Cancer
Start date: 2010-05-18
Prednisone
Dosage: 5 milligram
Start date: 2010-07-07
End date: 2010-07-13
Other drugs received by patient: Primaxin; Sodium Chloride; Sodium Chloride; Ketorolac Tromethamine; Hydromorphone HCL; Warfarin Sodium; Aranesp; Potassium Chloride; Piperacillin and Tazobactam; Lantus; Diflucan; Lotrimin; Demadex; Mycostatin; Vancomycin; Vancomycin; Ciprofloxacin HCL; Ciprofloxacin HCL; Famotidine; Lantus; Amlodipine; Atenolol; Aspirin; Humalog; Vancomycin; Acetaminophen; Hydromorphone HCL; Piperacillin and Tazobactam; Lantus; Flomax; Sodium Chloride; Hydrocodone; FAT Emulsion; Imdur; Imdur; Primaxin; Neulasta; Lortab; Furosemide; Lupron; Vancomycin; Pravastatin; Gastrografin; Imipenem and Cilastatin Sodium; Isosorbide Mononitrate; Demadex; Warfarin Sodium; Enoxaparin; Mephyton; Potassium Chloride; Imipenem and Cilastatin Sodium; Docusate Sodium; Adult TPN
Possible Prednisone side effects in female
Reported by a physician from United States on 2012-06-05
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: Productive Cough, Febrile Neutropenia, Upper Gastrointestinal Haemorrhage, Tooth Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 2200 mg
Doxorubicin HCL
Dosage: 120 mg
Etoposide
Dosage: 588 mg
Prednisone
Dosage: 1000 mg
Rituximab (Moab C2b8 Anti Cd20, Chimeric)
Dosage: 640 mg
Vincristine Sulfate
Dosage: 2.72 mg
Page 1 Next >>
|
